Pulmatrix, Inc. Fair Value Disclosure
Derivative Instruments | ||||
Balance — January 1, 2017 | $ | 35 | ||
Change in fair value | (34 | ) | ||
Balance — December 31, 2017 | 1 | |||
Change in fair value | (1 | ) | ||
Balance — December 31, 2018 | $ | — | ||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2018 | Feb 19, 2019 | Showing above |
| 2017 | Mar 13, 2018 | |
| 2016 | Mar 10, 2017 | |
| 2015 | Mar 10, 2016 | |
About Fair Value Disclosures
Fair value disclosures classify all assets and liabilities measured at fair value into a three-level hierarchy: Level 1 (quoted market prices), Level 2 (observable inputs like yield curves), and Level 3 (unobservable inputs requiring management estimates). The proportion of Level 3 assets directly reflects how much of the balance sheet depends on internal models rather than market evidence.
Key signals: a growing Level 3 balance relative to total fair-value assets increases valuation uncertainty and earnings volatility risk. Watch for transfers between levels — assets moving from Level 2 to Level 3 often signal deteriorating market liquidity. Unrealized gains and losses on Level 3 positions flow through earnings or other comprehensive income, so large swings deserve scrutiny. For financial institutions, examine the sensitivity disclosures that show how Level 3 valuations change under alternative assumptions. Compare the fair value of debt against its carrying amount to gauge hidden leverage.